GSK Annual Report 2002

37 Reconciliation to US accounting principles continued
Notes to the financial statements GlaxoSmithKline 135
2002 2001
Total assets by business sector £m £m
Pharmaceuticals 46,706 52,391
Consumer Healthcare 10,965 8,950
Total assets 57,671 61,341
Total assets by location of subsidiary undertaking
USA 22,727 25,741
Europe 20,982 20,865
International 11,414 12,256
Total operating assets 55,123 58,862
Cash and cash equivalents and marketable securities 2,548 2,479
Total assets 57,671 61,341
2002 2001
Total liabilities by business sector £m £m
Pharmaceuticals 16,816 15,757
Consumer Healthcare 5,126 4,615
Total liabilities 21,942 20,372
Total liabilities by location of subsidiary undertaking
USA 8,710 7,971
Europe 9,351 9,112
International 3,881 3,289
Total liabilities 21,942 20,372
2002 2001
Land and
Plant,
equipment Computer Assets in
Tangible fixed assets by location of subsidiary undertaking
buildings
£m
and vehicles
£m
software
£m
construction
£m
Total
£m
Total
£m
USA 691 379 29 378 1,477 1,611
Europe 1,729 1,833 111 649 4,322 4,210
International 533 370 11 151 1,065 1,194
Total 2,953 2,582 151 1,178 6,864 7,015
UK segment
Information is given separately in respect of the UK, which, although included in the Group’s Europe market region, is considered the
Group’s home segment for the purposes of segmental reporting.
2002 2001 2000
£m £m £m
Turnover by location of customer 1,366 1,328 474
Gross turnover 4,945 5,388 1,241
Inter-segment turnover (3,230) (3,753) (562)
Turnover by location of subsidiary 1,715 1,635 679
Operating profit 373 321 370
Total assets 8,253 6,962